Examines whether a high-dose radioimmunotherapy is needed in non-Hodgkin's lymphoma. Target molecules and antibodies for treating non-Hodgkin's lymphoma; Experience with clinical radioimmunotherapy in non-Hodgkin's lymphoma; Conventional low-versus myeloablative high-dose therapy.